Cord blood viable option for kids with life-threatening metabolic disorders

December 10, 2007

Children born with inherited metabolic disorders that cause organ failure and early death can be treated successfully with umbilical cord blood transplants from unrelated donors and, in some cases go on to live for many years, according to a study led by Duke University Medical Center researchers.

Umbilical cord blood transplant may confer advantages over bone marrow transplant, which has been the traditional method for treating these disorders, the researchers said.

"During the past 25 years, children with these disorders, which include Hurler disease and Krabbe leukodystrophy, have been treated successfully with bone marrow transplants but only if a matched donor was available," said Vinod Prasad, M.D., a pediatric hematologist/oncologist at Duke and lead investigator on the study. "Umbilical cord blood transplant can be done successfully from a mismatched donor, so it opens the possibility of treatment to many patients who otherwise would succumb to their disorders."

The researchers presented their findings on Dec. 10 at the American Society of Hematology meeting in Atlanta. The study was funded by the National Institutes of Health and Hunter's Hope Foundation, an organization founded in memory of former NFL quarterback Jim Kelly's son Hunter, who died from Krabbe disease, an inherited metabolic disorder that affects the nervous system.

"These disorders are rare when taken individually -- some of them occur in only one in a million births -- but if you put them together they have a sizeable incidence, maybe 1 in 10,000 births," Prasad said. "What these patients have in common is that they have some type of gene defect that causes them to lack a critical enzyme, required for the development of a vital organ, such as the heart or the brain or the nerves."

Without successful intervention, many of these children die before their first birthday, he said. Bone marrow and umbilical cord blood transplant work in these patients in much the same way -- by replacing missing enzymes and allowing the affected organs to develop more normally.

For this study, researchers looked at 159 children with inherited metabolic disorders who received unrelated cord blood transplants at Duke between 1995 and 2007.

"We saw that there were advantages to the unrelated cord blood transplant," Prasad said. "For instance, cord blood is more readily available than bone marrow and there was a decreased risk of complications, including a lower incidence of serious and potentially fatal graft-versus-host disease, which occurs when donor cells perceive a recipient's tissues and organs as foreign."

The study also suggests that when patients are transplanted while they are still relatively healthy, they have better outcomes than their counterparts who received bone marrow transplants.

"Over 88 percent of this subset of patients were alive one year after their cord blood transplants, and close to 80 percent were alive five years afterwards," Prasad said. "One reason for this could be the cord blood cells are immunologically more naïve than the blood-forming stem cells derived from bone marrow and therefore they may be more adaptable and less reactive once they get into the patient's body."

In a previous study looking at bone marrow transplant as a treatment for Hurler disease, which causes damage to the heart, liver and brain, only 35 percent of patients were alive five years after treatment, whereas 58 percent of all patients examined as part of the current study -- those with both high and lower functional status -- were alive after five years, Prasad said.

"Patients with inherited metabolic disorders who could benefit from transplantation should be referred early and diagnosis should be made early by enzyme testing, whenever possible," he said. "If we see them early enough they can have excellent short-term and hopefully long-term outcomes."

Duke has the largest cord blood transplant program in the country, and the first unrelated cord blood transplant was performed by Duke doctor Joanne Kurtzberg in 1993 on a patient with leukemia.

Source: Duke University Medical Center

Explore further: Researchers point way to improved stem cell transplantation therapies

Related Stories

Researchers point way to improved stem cell transplantation therapies

September 7, 2017
Researchers in Germany have demonstrated that hematopoietic stem cell (HSC) transplants can be improved by treatments that temporarily prevent the stem cells from dying. The approach, which is described in a paper to be published ...

Study of inherited herpes virus finds links to ancient humans

August 30, 2017
An international study of integrated HHV-6 has discovered that a small number of human ancestors, one from about 24,000 years ago, have been responsible for transmitting ancient strains of the virus to individuals today – ...

Genetically enhanced, cord-blood derived immune cells strike B-cell cancers

July 13, 2017
Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University ...

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Study points to novel way to improve outcomes from umbilical cord blood transplants

December 12, 2011
A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a ...

New therapy from naive cells attacks high-risk viruses in cord blood transplant patients

April 29, 2015
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and the Texas Children's Hospital have expanded the use of virus-specific cell therapy in cord blood transplant patients ...

Recommended for you

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.